Chaung Shang-Shing, Lin Chun-Ching, Lin Julian, Yu Kuo-Ho, Hsu Yu-Fang, Yen Ming-Hong
Department of Pharmacy, Kaohsiung Municipal Ta-tung Hospital, Kaohsiung, Taiwan, Republic of China.
Phytother Res. 2003 Aug;17(7):784-91. doi: 10.1002/ptr.1236.
In the present study, the hepatoprotective action of Limonium sinense (Plumbaginaceae) was evident after carbon tetrachloride (CCl(4)) and beta-D-galactosamine (D-GalN), respectively, challenge in rats. The plant materials were divided into two parts: (1) the roots extracted with water (WRE) and (2) the leaves extracted with methanol and fractionated with chloroform (CLE). Both WRE and CLE were extremely flavonoid-enriched extracts. In an CCl(4)-induced acute liver damage study, pretreatment with WRE at 300 mg/kg i.p. and CLE at 100 mg/kg i.p. significantly reduced the amino-transaminases levels of SGOT (p < 0.01) and SGPT (p < 0.01) previously increased by CCl(4) intoxication. In D-GalN-induced acute liver damage study, administration of WRE (300 and 500 mg/kg) or CLE (100 mg/kg) p.o. also significantly reduced the SGOT (p < 0.01) and SGPT (p < 0.01) levels previously increased by D-GalN intoxication. Furthermore, the serum triglyceride level was increased after pretreatment with WRE or CLE previously reduced by D-GalN intoxication. All of the liver function profiles were confirmed to have improvement of liver lesion in histopathological observation. In an acute toxicity test on ICR mice, the LD(50) of WRE was 777.6 mg/kg i.p. An in vitro study showed that CLE possessed a more potent cytotoxicity to human hepatocellular carcinoma cells (Hep3B) (EC(50) = 43.1 micro g/mL) than the other organic fractions, which were fractionated from methanol extracts of the leaves of L. sinense. The present results conclude that L. sinense possesses a hepatoprotective efficacy, and is relatively safe in rats.
在本研究中,中华补血草(蓝雪科)在大鼠分别受到四氯化碳(CCl₄)和β-D-半乳糖胺(D-GalN)攻击后,其肝脏保护作用明显。植物材料分为两部分:(1)用水提取的根(WRE)和(2)用甲醇提取并用氯仿分级分离的叶(CLE)。WRE和CLE均为富含黄酮类化合物的提取物。在CCl₄诱导的急性肝损伤研究中,腹腔注射300 mg/kg的WRE和100 mg/kg的CLE预处理可显著降低先前因CCl₄中毒而升高的谷草转氨酶(SGOT)(p < 0.01)和谷丙转氨酶(SGPT)(p < 0.01)水平。在D-GalN诱导的急性肝损伤研究中,口服WRE(300和500 mg/kg)或CLE(100 mg/kg)也可显著降低先前因D-GalN中毒而升高的SGOT(p < 0.01)和SGPT(p < 0.01)水平。此外,先前因D-GalN中毒而降低的WRE或CLE预处理后,血清甘油三酯水平升高。所有肝功能指标在组织病理学观察中均证实肝脏损伤有所改善。在对ICR小鼠的急性毒性试验中,WRE的腹腔注射半数致死量(LD₅₀)为777.6 mg/kg。体外研究表明,CLE对人肝癌细胞(Hep3B)的细胞毒性(半数有效浓度(EC₅₀) = 43.1 μg/mL)比从中华补血草叶甲醇提取物中分级分离得到的其他有机级分更强。目前的结果表明,中华补血草具有肝脏保护功效,并且在大鼠中相对安全。